期刊文献+

调强放疗联合化疗在局部晚期口咽癌治疗中的作用 被引量:2

Role of intensity-modulated radiotherapy combined chemotherapy for locally advanced Oropharyngeal carcinoma
原文传递
导出
摘要 目的探讨调强放疗联合化疗治疗局部晚期口咽癌的临床效果。方法选取66例局部晚期口咽癌患者,随机分为观察组和对照组,每组33例。观察组患者给予调强放疗联合化疗,对照组患者给予常规放疗联合化疗,两组化疗方案相同。所有患者先接受1~2个周期紫杉醇+顺铂(TP)方案诱导化疗,放疗开始后予以顺铂同步化疗。比较两组患者3年局部控制率(LRC)、无病生存率(DFS)、总生存率(OS)及不良反应发生率。结果 66例局部晚期口咽癌患者的1、3年生存率分别为94.0%和82.0%,其中观察组患者3年LRC、DFS和OS分别为97.0%、91.0%和94.0%,对照组患者分别为82.0%、76.0%和70.0%,差异有统计学意义(均P〈0.05)。观察组患者放射性皮炎和口腔干燥发生率明显低于对照组患者,差异有统计学意义(P〈0.05)。结论调强放疗联合化疗可提高局部晚期口咽癌患者的局部控制率、无病生存时间和总生存时间,有助于患者口咽功能的保护,改善患者生存质量,具有较好的临床效果和安全性,值得临床推广应用。 Objective A prospective study for the Role of Intensity-modulated radiotherapy combined chemotherapy in locally advanced oropharyngeal carcinoma,to assess the feasibility of this methods.Methods From March 2009 to March 2010,66 patients with advanced oropharyngeal carcinoma were treated with radiotherapy,these patients were randomly divided into IMRT plus chemotherapy group(observation group) and CRT plus chemotherapy group(control group) with 33 cases in each.The method of chemotherapy of two groups were the same.All the patients received induction chemotherapy with 1 ~ 2 cycles TP(PTX + DDP) regimen,DDP was used in concurrent radiochemotherapy.The local contral rate(LRC),disease free survival(DFS),overall survival(OS) and Adverse effects rate of the two groups were comparted.Results The 1,3-year overall survival rates were 94.0% and 82.0%.The local contral rate,disease free survival and overall survival were 82.0%,76.0% and 70.0% in the observation group,which were all higher than those of the control group(82.0%,76.0% and 70.0%,P 〈 0.05 for all).The major toxic and side effects were myelosuppression,gastrointestinal reactions,acute radiation stomatitis,radiodermatitis and xerostomia.The incidence of III-IVradioermatitis reactions and xerostomia in observation group were lower than those in group B(P 〈 0.05).Conclusion Intensity-modulated radiotherapy Combined Chemotherapy can not merely improve the efficacy of patients with locally advanced oropharyngeal carcinoma,but also keep the oropharyngeal function in patients and improve quality of life.
出处 《中国肿瘤临床与康复》 2014年第11期1352-1355,共4页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 口咽肿瘤 调强放疗 药物疗法 Oropharyngeal neoplasms Intensity modulated radiation Drug therapy
  • 相关文献

参考文献15

  • 1Huang K, Xia P, Chuang C, et al. Intensity-modulated chemo- radiation for treatment of stage Ⅲ and Ⅳ oropharyngeal carcino- ma:The University of California-San Franciso experience[ J]. Cancer, 2008,113:497-507.
  • 2Megan ED, Quynh TL, Daniel C, et al. Intensity-modulated ra- diotherapy in the treatment of oropharyngeal cancer: clinical out- comes and patterns of failure [ J]. Int J Radiat Oncol Biol Phys, 2010, 76 : 1339-1346.
  • 3Sebastion C, David HA, Bernard F, et al. Simultaneous inte- grated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma [ J]. Int J Radiat Oncol Biol Phys, 2012, 82: 582-589.
  • 4Denittis AS, Maehty M, Rosenthal DI, et al. Advanced oropha- ryngeal carcinoma treated with surgery and radiotherapy: Onco- logic outcome and functional assessment [ J ]. Am J Otolaryngol, 2001,22:329-335.
  • 5惠蓓娜,张晓智,王蕊华,李毅.颈段、胸上段食管癌3DCRT/IMRT剂量学比较[J].临床肿瘤学杂志,2012,17(1):36-41. 被引量:12
  • 6Bourhis J, Overgaard J, Audry H, et al. Hypeffractionated or accelerated radiotherapy in head and neck cancer:a meta-analy- sis[J]. Lancet, 2006, 368:843-854.
  • 7Orlandi E, Palazzi M, Pignoil E, et al. Radiobiological basis and clinical results of the simultaneous integrated boost(SIB) in intenstiy modulated radiotherapy (IMRT)for head and neck cane-er: A review[ J ]. Crit Rev Oncol Hematol, 2010, 73 : 111-125.
  • 8Lorch JH, Goloubeva O, Haddad RJ, et al. Induction chemo- therapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck; long-term results of the TAX324 randomised phase 3 trial[J]. Lancet Oncol, 2011, 12:153-159.
  • 9Cmelak AJ, Li S, Goldwasser MA, et al. Phase II trial of che- moradiation for organ preservation in reseetable stage Ⅲ-Ⅳ squamous cell carcinomous of the larynx or oropharynx : results of Eastern Cooperative Ontology Group Study E2399 [ J ]. J Clin Oncol, 2007, 25:3971-3977.
  • 10Lee NY, de Arruda FF, Purl DR, et al. A comparison of inten- sity-modulated radiation therpy and concomitant boost radiother- apy in the setting of concurrent chemotherapy for locally ad- vanced oropharyngeal carcinoma [ J ]. Int J Radiat Oncol Biol Phys, 2006, 66:966-974.

二级参考文献10

  • 1李晓敏,章荣棻,郭丹,王静怡,王鹤皋.食管癌后程加速超分割放射治疗的临床疗效分析[J].中国肿瘤临床,2006,33(18):1025-1028. 被引量:8
  • 2Parliament M, Alidrisi M, Munroe M, et al. Implication of radiation dosimetry of the mandible in patients with carcinomas of the oral cavity and nasopharynx treated with intensity modulated radiation therapy. Am J Oral Maxillofac Surg,2005,34 : 114-121.
  • 3Yao M, Dornfeld KJ, Buatti JM, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys,2005,3 : 410-421.
  • 4Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol, 1998,16 : 139-144.
  • 5Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer:a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys, 1994,28:847-856.
  • 6Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity modulated irradiation of head and neck eaneer. Int J Radiat Oncol Biol Phys, 1999,45:577-587.
  • 7de Graeff A, de Leeuw JR, Ros WJ, et al. A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol, 1999,35:27-32.
  • 8Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys,2005 ,63 :725-731.
  • 9傅卫华,王绿化,周宗玫,戴建荣,胡逸民.上段食管癌SIB-IMRT治疗计划比较[J].中国医学科学院学报,2003,25(3):337-342. 被引量:47
  • 10Wei-HuaFu Lu-HuaWang Zong-MeiZhou Jian-RongDai Yi-MinHu Lu-JunZhao.Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma[J].World Journal of Gastroenterology,2004,10(8):1098-1102. 被引量:92

共引文献11

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部